| INTRODUCTION
According to the data statistics, oral cavity and oropharynx cancer is one of the top 10 malignancies in developing countries with an incidence of approximately 300 400 new cases in 2012 worldwide.
Smoking, alcohol consumption, and HPV infection are considered to be highly correlated to oral cavity and oropharynx cancer. Despite various new therapeutics, such as heavy-ion radiotherapy and targeted chemotherapy, have been developed in last several decades, the 5-year survival rate is still <50%, with an estimated 145 400 cancer-related deaths a year. 1 Squamous cell carcinomas (SCC) are the most frequent histological type in oral cavity and oropharynx cancer. It is acknowledged that the primary tumor topography, cervical lymph node status, and distant metastasis, which is also known as the TNM stage, predict the prognosis of oral cavity and oropharynx squamous cell carcinomas (OSCC). 2 However, it is undeniable that that there are sharp prognostic differences in some patients with the same TNM stage. Serum markers have been paid
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increasing attention during the past few years, due to their simplicity and easy acquirement.
Serum liver enzymes, including alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP), adenosine deaminase (ADA) etc., play an integral role in metabolism of the body which catalyze relevant catabolic pathways, such as amino acid metabolism, skeleton development, and maintenance of the immune system. Due to their biological characteristics, their concentration in the serum has been commonly measured clinically as markers in diagnosing hepatic disorders.
Recent studies have stated the associations between serum levels of enzymes above and prognosis of different kinds of cancers. For example, higher GGT or ALP levels have been demonstrated to predict poor overall survival (OS) or disease-free survival (DFS) in patients with colorectal, cervical, breast, endometrial, and esophageal cancers. [3] [4] [5] [6] [7] Moreover, patients with malignant tumors, such as ovarian or oral cavity cancer, had higher serum ADA levels compared to normal controls and there were significant differences between the histopathological grade and ADA levels. 8, 9 Therefore, it seems that liver enzymes activities have a negative effect on prognosis of malignancies. However, there is deficiency in studies discussing the relationship between OSCC and serum liver enzymes level, no adequate survival data are involved in prognostic analyses. Here, we conducted a study involving 134 OSCC patients to investigate whether liver enzymes levels are associated with survival outcomes and detect probable prognostic biomarkers for OSCC.
| MATERIAL AN D METHODS

| Subjects
We retrospectively reviewed a total of 134 patients who were histopathologically confirmed oral and oropharynx cancer squamous 
| Clinical and pathological parameters
The following parameters were included in our analyses: age, gender, were considered significant and the confidence level was 95% confidence intervals (CIs). 
T A B L E 1 Baseline characteristics of OSCC patients
| Baseline characteristics of patients
A total of 134 patients with OSCC were recruited in this study for analysis of serum liver enzymes. At the end of the follow-up, 24 (17.91%) patients died and 34 (25.37%) patients were associated with relapse. The median age was 60 years with a range from 23 years to 83 years. There were no obvious differences in sex distribution (73 men vs 61 women). Table 1 illustrates the detailed baseline characteristics of patients with OSCC. All patients were followed up for 6-67 months with a median time of 31.5 months and their interquartile range followed up time was 19.0 to 50 months.
The OS and DFS of patients are illustrated in Figure 1A ,B.
| Association between serum liver enzymes and clinical outcomes
We first explored whether any of serum liver enzymes could be a prognostic factor for OSCC patients. Univariate cox regression tests were performed because values of those enzymes were continuous numerical variables and only ADA was turned out to be significant in terms of OS and DFS (P = 0.006 and P = 0.024, respectively, Table 2 ). However, continuous variables are not convenient for clinical practice. X-tile software was then used to calculate the optimal cutoff values of ADA, which happens to be 17.2 U/L for both OS and DFS (Figure 2 ). Thus, we changed continuous variables into dichotomous variables and we described ADA >17.2 U/L as higher ADA and ADA ≤17.2 U/L as lower ADA. 
patients' OS and DFS
We further investigated associations between different clinical parameters and patients' survival outcomes. When P value of univariate analyses was <0.1, the corresponding parameters were defined as potential prognostic predictors. Log-rank tests with Kaplan-Meier method showed that patients older than 60 years, with advanced tumor status and lymph node classification, with poor histological differentiation and higher ADA potentially associated with poor OS (P = 0.088, P = 0.002, P = 0.002, P = 0.028, and P = 0.003, respectively, Table 3 ) and shorter DFS (P = 0.077, P = 0.035, P = 0.005, P = 0.028, and P = 0.011, respectively, Table 4 ). We next conducted multivariate cox regression analyses including potential predictors to ascertain independent prognostic factors of patients'
survival. The statistical results demonstrated that lymph node status (P = 0.035) as well as serum ADA level (P = 0.019) independently predicts OS of patients with OSCC (Table 3 , Figure 1C ). In addition, age (P = 0.043) and lymph node status (P = 0.027) are independently prognostic parameters for patients' DFS. Serum ADA (P = 0.093) lost its significance when it comes to DFS ( Table 4 , Figure 1D ).
| DISCUSSION
It is convinced that assessing accurately prognosis of cancer patients is helpful for surgeons to select appropriate therapies. We have been committed to discover suitable serum biomarkers in prediction of clinical outcomes of patients with OSCC. In our previous studies, 
F I G U R E 2
The optimal cutoff value of serum ADA levels for OS (A) and DFS (B) of patients with OSCC by X-tile software. Left panels show X-tile plots of all patients and the bottom black dot represents the optimal cutoff values, which are also shown on histograms of the entire cohort in middle panels. Kaplan-Meier curves for ADA associated with survival are displayed in right panels ZHU ET AL. ADA, which belongs to sulfhydryl proteases, is considered a key enzyme of purine nucleoside metabolic pathway and DNA metabolism. Two isoforms of ADA have been recognized, which are ADA1
and ADA2. The former one is found in almost all human tissues and it participates actively in intracellular activities. 15 The latter one, first detected in human spleen, is predominantly in the mononuclear phagocyte system. 16 ADA irreversibly catalyzes deamination of adenosine by substituting the keto group for the amino group and consequently, adenosine is transformed into related nucleoside inosine.
ADA plays a critical in the maintenance and development of the human being's immune, neural, and vascular systems, especially in the growth of B and T lymphocytes. 17 Deficiency of ADA can cause accumulations of dexoyadenosine triphosphate leading to severe combined immunodeficiency (SCID) which can be fatal in humans. 18 Conversely, it is well-known that elevated levels of ADA can occur when dysfunctions of liver, blood system, such as aplastic anemia, happen. This study excluded patients with aforementioned diseases, reducing influence of confounding biases to the experimental results.
Increasing evidences of alterative ADA levels in various types of cancer has been observed in current researches. Most of them showed a rising tendency, including bladder, breast, ovarian, gastric, colonic, and head-and-neck malignancies. activities in patients with breast cancer than those in the benign and healthy subjects (P < 0.005 and P < 0.001, respectively), hence they concluded that total ADA and ADA2 activities might be used as a diagnostic test to differentiate mammary benign and malignant dis- In this study, we revealed that higher ADA levels were independently associated with poor OS. Leakage of ADA from primary cancer cells may partially explain this result. 14 Cancer cells with higher malignant degree could contain higher extracellular adenosine levels, which essentially results from ATP enzymatic phosphohydrolysis by the ecto-nucleotidases CD39 and CD73. 27 When binding to different receptors (A1, A2a, A2b, and A3), the extracellular adenosine help malignant cells evade immune surveillance and foster proliferation and migration of them. 28 Thus, rising extracellular adenosine levels may lead to a concomitant increase in ADA levels. Also, studies have revealed that proliferation of cancer cells could be affected by ADA inhibitors that suppress DNA synthesis due to accumulations of deoxynucleotides and dexoyadenosine. 29, 30 Therefore, ADA may accelerate DNA turnover and nucleotide metabolism of malignant cells to simulate and accelerate the growth of malignancies. Given that lymph nodes metastases were also an independent predictor for both OS and DFS, we consider that those OSCC patients with higher
ADA and positive lymph nodes should be treated more aggressively, such as expanding the resection domain of primary lesion of OSCC and modest extension of chemoradiotherapy indications, and the follow-up internals ought to be shorten. However, more clinical data should be obtained to confirm or amend our suggestions.
Limitations were observed in our study undoubtedly. First, distribution of tumor site was uneven, which may cover up impacts on serum ADA levels by different locations of cancers. Second, postoperative serum ADA levels in OSCC patients were unknown in the study; we were unable to investigate the association between changes of ADA and OS or DFS of patients. Moreover, this was a single-center cohort study and the follow-up duration was short.
Therefore, it is expected that a multi-center study with sufficient follow-up time and large clinical samples will be performed in future.
| CONCLUSION
This study based on 134 OSCC samples disclosed a primary association between serum liver enzymes and survival. Elevated pre-treatment serum ADA levels were independently associated with poorer OS. To sum up, the authors propose that pre-operative serum ADA may serve as an independent prognostic predictor for OS in OSCC patients.
ACKNOWLEDG EMENTS
This study is supported by the National Natural Science Foundation of China (grant numbers 81402236, 81772887), the Priority Aca- 
CONF LICT OF I NTEREST
The authors declare no conflicts of interest.
O R C I D
Xiaomeng Song https://orcid.org/0000-0002-6929-4268
